Literature DB >> 23462185

Sinonasal teratocarcinosarcoma: a clinicopathologic and immunohistochemical study of 6 cases.

Syeda Samia Fatima1, Khurrum Minhas, Nasir Ud Din, Saira Fatima, Arsalan Ahmed, Zubair Ahmad.   

Abstract

Teratocarcinosarcoma (TCS) is a rare and unusual malignant neoplasm of the sinonasal tract with a heterogenous morphology and an aggressive behavior. Patients are predominantly adults with a male predominance. The aim of this study was to describe clinicopathologic and immunohistochemical features of 6 cases of TCS. The ages ranged from 18 to 67 years (mean, 33 years) with a male-to-female ratio of 5:1. Most tumors were located in the nasal cavity. Nasal obstruction and epistaxis were the common presenting symptoms. Histologically, all tumors exhibited a heterogeneous morphology with varying proportions of benign and malignant epithelial, mesenchymal, and neuroepithelial elements. Adenocarcinoma was the malignant epithelial component in all cases. The mesenchymal elements were composed of benign to malignant spindle cells. Osteosarcomatous areas were seen in 2 cases and rhabdomyosarcoma in 1 case. Rhabdoid differentiation was also seen in 1 case. Immunohistochemical stains CKAE1/AE3 and CK Cam 5.2 were positive in the epithelial elements, vimentin in mesenchymal, and CD56 and neuron-specific enolase in neuroepithelial elements. Follow-up was available in 4 patients and ranged from 21 to 40 months (mean, 31 months). Lung and dura metastasis, respectively, were seen in 1 patient each. However, all 4 patients are alive and free of disease to date. In conclusion, TCS is a rare but highly malignant tumor with aggressive behavior characterized by benign and malignant epithelial, mesenchymal, and neuroepithelial components. Two patients in our series were younger than 20 years. The occurrence of rhabdoid differentiation and osteosarcomatous component seen in our series were rarely described in literature. Recognition of all the components requires adequate sampling, which is crucial for a correct diagnosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoradiation; Dura; Lung; Metastasis; Nasal cavity; Teratocarcinosarcoma

Mesh:

Substances:

Year:  2013        PMID: 23462185     DOI: 10.1016/j.anndiagpath.2013.01.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  8 in total

1.  Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.

Authors:  Austin McCuiston; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-06-14

2.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2022-03-21

3.  Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-catenin Overexpression and a β-catenin Mutation.

Authors:  Andrew C Birkeland; Sarah J Burgin; Megan Yanik; Megan V Scott; Carol R Bradford; Jonathan B McHugh; Scott A McLean; Stephen E Sullivan; Jacques E Nor; Erin L McKean; J Chad Brenner
Journal:  J Neurol Surg B Skull Base       Date:  2017-03-27

4.  Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis.

Authors:  Nikita Chapurin; Douglas J Totten; Justin C Morse; Mohammad S Khurram; Peter C Louis; Robert J Sinard; Naweed I Chowdhury
Journal:  Am J Rhinol Allergy       Date:  2020-09-20       Impact factor: 2.467

5.  SALL-4 and Beta-Catenin Expression in Sinonasal Teratocarcinosarcoma.

Authors:  Margaret L Compton; James S Lewis; William C Faquin; Nicole A Cipriani; Qiuying Shi; Kim A Ely
Journal:  Head Neck Pathol       Date:  2021-06-09

6.  Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-Catenin Overexpression and a β-Catenin Mutation.

Authors:  Simone Minasi; Ludovica De Vincentiis; Aurelio D'Ecclesia; Alessandro Corsi; Felice Giangaspero
Journal:  J Neurol Surg B Skull Base       Date:  2019-12-02

7.  Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature.

Authors:  Sarthak Tandon; Munish Gairola; Parveen Ahlawat; Kanika Sharma; Soumitra Barik; Nishtha Sachdeva; Sunil Pasricha; Apeksha Shenoy
Journal:  Radiat Oncol J       Date:  2018-12-07

8.  A rare case of intracranial teratocarcinosarcoma: Case report and review of literature.

Authors:  Christopher J Elia; Marc Cabanne; Zhe Piao; Andrew Lee; Todd Goldenberg; Vaninder Chhabra
Journal:  Surg Neurol Int       Date:  2018-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.